General


Peptide: C16G2
Microorganism:Streptococcus mutans
Administration:
Stage: Preformed biofilm
Notes:S. mutans clinical isolate UA140

Experimental procedure


Method AMP Effect(Biofilm reduction) Concentration Notes
Resazurin assay > 90% 25 uM

Reference



M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.

Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or gpmaccari@gmail.com